Acridanone derivatives

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/211, 260/277

C07D 417/12 (2006.01) A61K 31/47 (2006.01) C07D 219/06 (2006.01) C07D 219/10 (2006.01) C07D 417/14 (2006.01)

Patent

CA 1258854

Abstract The present invention is concerned with acridanone derivatives of the general formula Image I wherein the dotted line signifies an optional bond, R1 signifies hydrogen, halogen or nitro, R2 signifies hydrogen or lower alkyl, one of the substituents R3 and R4 signifies hydrogen or lower alkyl and the other together with R sig- nifies an additional bond, A signifies lower alkylene, R5 signifies a 5-membered nitrogen-containing, optionally lower alkyl-substituted aromatic heterocycle, amino or the group Image the symbol ? signifies a 5- or 6-membered, optionally lower alkyl-substituted saturated - ii - heterocycle which can contain as a ring member an oxygen or sulphur atom or the group ?NH or ?N(B)n-A1-R6, B signifies the group -CO-, -COO- or -SO2-, n signifies the number 0 or 1, A1 signifies lower alkylene, R6 signifies hydrogen, amino, lower alkylamino or di(lower alkyl)amino and R7 signifies hydrogen or lower alkyl, and pharmaceutically acceptable acid addition salts thereof, their manufacture and pharmaceutical preparations based thereon. These novel substances possess valuable pharmacological properties and can be used in the control or prevention of illnesses. In particular, they display valuable schistosomicidal activities and can accordingly be used in the control or prevention of schistosomiasis.

440203

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Acridanone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Acridanone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acridanone derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1173024

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.